The immunopathology of human schistosomiasis-III. Immunoglobulin isotype profiles and response to praziquantel

Memorias do Instituto Oswaldo Cruz

Volumn 91, Issue 5, 1996, Pages 593-599

  Ramírez, Romelia M ^a   Ceballos, Evelia ^a   De Noya, Belkisyolé Alarcón ^a   Noya, Oscar ^a   Bianco, Nicolás ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Immunoglobulin; Isotypes; Praziquantel; Schistosoma mansoni

Indexed keywords

SCHISTOSOMA MANSONI;

ANTIPLATYHELMINTIC AGENT; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; PRAZIQUANTEL;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; DRUG EFFECT; HUMAN; IMMUNOLOGY; SCHISTOSOMA MANSONI;

ADOLESCENT; ADULT; ANTIPLATYHELMINTIC AGENTS; CHILD; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; PRAZIQUANTEL; SCHISTOSOMIASIS MANSONI;

EID: 0030225251     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761996000500010     Document Type: Article

References (51)

1. Anonymous 1992. Praziquantel shows unexpected failure in recent schistosomiasis outbreak. TDR News 41: 1-2.
2. Alarcón de Noya B, Spencer L, Noya O 1992. Pre- and Post-treatment immunodiagnostic evaluation in human schistosomiasis mansoni. Mem Inst Oswaldo Cruz 87 (Supp IV) 271-276.
3. Aldrey O, Noya B, Machado I, Noya O, Bianco NE, Perez GE 1988. Immunopathology of human schistosomiasis mansoni I. Immunomodulatory influences on T cell function. Rev Inst Med Trop São Paulo 30: 393-399.
4. Andrews P, Thomas H, Pohlke R, Seubert J 1983. Praziquantel. Med Res Rev 3: 147-200.
5. Benarroch LK, Noya O, Noya B, Bianco NE, Blanca I 1988. Immunopathology of human schistosomiasis mansoni II. Rev Inst Med Trop São Paulo 30: 400-405.
6. Black CM, Plikaytis BD, Wells TM, Ramírez RM, Carlone GM, Chilmonczyk BA, Reimer CB 1988 Two sites immunoenzymometric assays for serum IgG subclass infant/maternal ratios at full term. J Immunol Methods 106: 71-81.
7. 4. Clin Exp Immunol 82: 574-578.
8. Brindley PJ, Scher A 1987. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol 139: 215-220.
9. Butterworth AE 1987. Immunity in human schistosomiasis. Acta Tropica 44 (Suppl 12) 31-40.
10. Butterworth AE, Bebsted-Smith R, Capron A, Capron M, Dalton PR, Dunne DW, Grzych JN, Kariuki HC, Khalife J, Koech D, Mugambi M, Ouma JH, Arap Siongok TK, Sturrock RF 1987. Immunity in human schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children. Parasitology 94: 281-300.
11. Butterworth AE, Capron M, Cordingley JS, Dalton PR, Dunne DW, Kariuki HC, Kimani G, Koech D, Mugambi M, Ouma JH, Prentice MA, Richardson BA, Arap Siongok TK, Sturrock RF, Taylor DW 1985. Immunity after treatment of human schistosomiasis mansoni II. Identification of resistant individuals, and analysis of their immune response. Trans R Soc Trop Med Hyg 79: 393-408.
12. 2 anti-carbohydrate antibodies block the expression of immunity in young children. Biochimie 70: 1053-1063.
13. Cancio M, Rivera de Sala A, Ramírez de Arellano G, Rodríguez-Molina R 1967. Circumoval antibodies measurements during treatment of experimental schistosomiasis. Am J Trop Med Hyg 16: 729-734.
14. Cioli D, Pica-Maltoccia L, Archer S 1993. Drug resistance in schistosomes. Parasitol Today 9: 162-166.
15. Cline BA, Almeida Machado P, Almoatz Billah M, Mao SP, Shao BR 1982. The control of schistosomiasis in Brazil, Egypt and China. Am J Trop Med Hyg 31: 75-102.
16. Colley DG, Cook JA, Freeman GL, Bartholomew RK, Jordan P 1977. Human response during human schistosomiasis mansoni I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparation from schistosome eggs, worms and cercariae. Int Arch Allergs Appl Immun 53: 420-433
17. De Jonge N, Rabello ALT, Krijger FW, Kremsher PG, Rocha Katz N, Decider AM 1991. Levels of the circulanting anodic and cathodic antigens in serum of schistosomiasis patients from Brazil. Trans R Soc Trop Med Hyg 85: 756-759.
18. 2 in immunity to reinfection after chemotherapy. J Inf Dis 168: 1000-1008
19. Dunne DW, George V, Hillyger V, Vazquez G 1988. Schistosoma mansoni cationic egg antigens (CEF): Immunoserology with oxamniquine-treated patients and involvement of CEF6 in the circumoval precipitin reaction Am J Trop Med Hyg 38: 508-514.
20. 1) from Schistosoma mansoni eggs. Parasitology 103: 225-236.
21. 1) from Schistosoma mansoni eggs is putatively hepatotoxic in T-cell deprived mice. Trans R Soc Trop Med Hyg 75, 54-71
22. Evengard B, Hammarstrom L, Smith CIE, Johansson SGO, Linder E 1988. Subclass distribution and IgE responses after treatment in human schistosomiasis. Clin Exp Immunol 73 383-388.
23. Fallon PG, Doenhoff MJ 1994. Drug-resistant schistosomiasis resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51: 83-88.
24. Gascan H, Gauchat JF, Aversa G, Van-Vlasselaer P, de Vries JB 1991. Ati-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways J Immnnol 174: 8-13.
25. 4, and resistance to reinfection with Schistosoma haematobium Nature 349: 243-245.
26. 4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immun 66: 200-207.
27. Jassim A, Hassan K, Catty D 1987. Antibody isotypes in human schistosomiasis mansoni Parasite Immunology 9: 627-650.
28. Katz N, Chaves A, Pellegrino J 1972. A simple device for quantitative stool thick smear technique in schisotosomiasis mansoni. Rev Inst Med Trop São Paulo 14: 397-400.
29. Katz N, Rochas RS, De Soriza CP, Filho PC, Bruce JI, Coles GE, Kinoli GK 1991. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment. Am J Trop Med Hyg 44, 509-512.
30. Klein F, Skavaril F, Vermeeren T, Vlug A, Duimel WJ 1985. The quantification of human IgG subclasses for reference preparation. Clin Chem Acta 150: 119.
31. 2 Trans R Soc Trop Med Hyg 75: 72-79.
32. Martin LK, Beaver PC 1968. Evaluation of the Kato thick smears technique for the quantitative diagnosis of helmintic Am J Trop Med Hyg 17: 382-390.
33. Mendlovic F, Tarrab-Hazdai R, Arnon R 1987. Role of humoral immunity and helper cell involvement in permissiveness to infection of Schistosoma mansoni. Eur J Immunol 17: 1151-1157.
34. Modha J, Lambertucci JR, Doenhoff MJ, McLaren D 1990 Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worm exposed to praziquantel and immune serum in vivo. Parasite Immunol 12: 321-334
35. Mott K, Cline B 1980 Advances in epidemiology survey methodology and techniques in schistosomiasis. Bull WHO 58: 639-647.
36. Mott KE, Dixon H 1982. Collaborative study on antigens for immunodiagnosis of schistosomiasis. Bull WHO 60. 729-753
37. Noya O, Fermin S, Alarcón de Noya B, Losada S, Colmenares C, Hermoso T 1995a. Humoral immune response of children with chronic schistosomiasis Isotypic recognition of adult worm antigens. Parasite Immunol 17: 319-328.
38. Noya O, Losada S, Alarcón de Noya B, Gonzales S, Hermoso T, Balzan C, Cesari IM 1995b. Effect of chemotherapy in immune response to egg antigens of Schistosoma mansoni in chronically infected children from areas of low transmission. Parasite Immunol 17: 111-117.
39. Oliver-Gonzalez J, 1954. Anti-egg precipitins in sera of humans infected with Schistosoma mansoni. J Infect Dis 95: 86-91.
40. Pointier JP, McCullough F 1989. Biological control of the snail hosts of Schistosoma mansoni in the Caribbean area using Thiara spp. Acta Tropica 46: 147-155.
41. Reimer CB, Black CM, Holman RC, Wells TW, Ramirez RM, Sa-Ferreira JA, Janet KA, Nicholson JKA, McDougal JS 1988. Hypergammaglobulinemia associated with human immunodeficiency virus infection. Monogr in Allerg 23: 83-96
42. Reimer CB, Smith S, Wells T, Nakamura R, Keitges P, Williams G, Hanson D, Dorsey D, 1982. Collaborative calibration of the U.S. National and American Pathologists reference preparations for specific serum proteins. Am J Clin Path 77: 12-19.
43. Rifaat M, Ismail I, El Mahallawy M, Awaad S, Essawy M 1969. Comparative study of some immunological tests for schistosomiasis before and after treatment. Trans R Soc Trop Med Hyg 63: 338-342.
44. Rihet P, Demeure E, Bourgouis A, Prata A, Dessein AJ 1991. Evidence for an association between human resistance to Schistosoma mansoni and high antilarval IgE levels. Eu J Immunol 21: 2679-2686.
45. Rowe DS, Anderson SG, Tackett L 1970. A research standard for human serum immunoglobulin D. Bull WHO 43: 607-609.
46. Rowe DS, Grab B, Anderson SG 1972. An international reference preparation for human serum immunoglobulins G, A and M: content of immunoglobulin by weight. Bull WHO 46: 67-69.
47. Rowe DS, Grab B, Anderson SG 1973. An international reference preparation for human scrum immunoglobulin E. Bull WHO 49: 320-321.
48. Sabah AA, Fretcher C, Webbe C, Doenhoff MJ 1985. Schistosoma mansoni reduced efficacy of chemotherapy in infected T-cell deprived mice. Exp Parisit 60: 348-352.
49. Tavares Neto J, Prata A 1988. Reação da forma hepato esplênica da esquistosomose em relação à raça. Rev Soc Bras Med Trop 21: 131-133.
50. WHO 1985. The control of schistosomiasis. World Health Organization Technical Report Series 728.
51. Xiao S, Catto BA, Webster LT 1985. Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J Infect Dis 151: 1130-1137.